Home » Stocks » Zivo Bioscience

Zivo Bioscience Inc. (ZIVO)

Stock Price: $0.149 USD -0.001 (-0.73%)
Updated Oct 22, 2020 9:38 AM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 60.59M
Revenue (ttm) 20,000
Net Income (ttm) -9.62M
Shares Out 406.92M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 22, 2020
Last Price $0.149
Previous Close $0.150
Change ($) -0.001
Change (%) -0.73%
Day's Open 0.149
Day's Range 0.149 - 0.149
Day's Volume 4,015
52-Week Range 0.05 - 0.18

More Stats

Market Cap 60.59M
Enterprise Value 65.82M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 406.92M
Float 239.57M
EPS (basic) -0.03
EPS (diluted) -0.03
FCF / Share -0.01
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.53
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 3,029.48
PB Ratio n/a
Revenue 20,000
Operating Income -8.78M
Net Income -9.62M
Free Cash Flow -3.10M
Net Cash -5.23M
Net Cash / Share -0.01
Gross Margin 100.00%
Operating Margin -43,916.55%
Profit Margin -48,114.20%
FCF Margin -15,501.29%
ROA -3,278.02%
ROE n/a
ROIC 227.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue--------0.100.08
Revenue Growth--------25.59%-
Gross Profit---------0.030.03
Operating Income-8.35-6.13-6.33-3.49-3.06-5.15-3.11-2.08-1.94-4.06
Net Income-11.51-14.64-10.04-6.06-5.790.68-10.10-3.25-2.73-7.12
Shares Outstanding27615713913413112511210196.5887.16
Earnings Per Share-0.04-0.09-0.07-0.05-0.04--0.09-0.03-0.03-0.08
Operating Cash Flow-3.71-5.01-4.24-2.54-2.30-2.74-2.99-1.77-1.29-1.44
Capital Expenditures----------0.03
Free Cash Flow-3.71-5.01-4.24-2.54-2.30-2.74-2.99-1.78-1.30-1.47
Cash & Equivalents0.350.390.320.510.020.000.490.170.350.14
Total Debt5.2818.1513.9610.316.164.012.511.340.520.28
Net Cash / Debt-4.93-17.77-13.64-9.80-6.14-4.01-2.02-1.16-0.17-0.14
Assets0.370.410.330.740.070.102.170.230.460.34
Liabilities8.7122.6916.6414.369.576.4711.774.192.491.29
Book Value-8.34-22.28-16.30-13.62-9.50-6.37-9.59-3.96-2.03-0.95
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Zivo Bioscience Inc.
Country United States
Employees 5
CEO Andrew A. Dahl

Stock Information

Ticker Symbol ZIVO
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: ZIVO

Description

ZIVO Bioscience, together with its subsidiaries, engages in licensing and marketing natural bioactive ingredients derived from its proprietary algal cultures. The company provides its natural bioactive ingredients to animal, human and dietary supplement, and medical food manufacturers; and intends to license its bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications. It is also involved in developing, manufacturing, marketing, and selling tests that would allow people to optimize their health and identify future health risks, as well as provides insurers, employers, and healthcare providers with timely information to intervene with wellness programs, fitness regimes, or other preventative measures. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Keego Harbor, Michigan.